Deals & Capital Markets
Gilead Pays $7.8B to Take Full Control of CAR-T Challenger to J&J's Carvykti
4d ago
You're signed outSign in or to get full access.
Leadership at GILEAD SCIENCES
Browse executives, board members, and key leadership.
Executives at GILEAD SCIENCES
Daniel P. O’Day
Chairman and Chief Executive Officer
CEO
Executive
Board
Andrew D. Dickinson
Chief Financial Officer
Executive
Deborah H. Telman
Executive Vice President, Corporate Affairs and General Counsel
Executive
Dietmar Berger
Chief Medical Officer
Executive
Erin Burkhart
Senior Vice President, Controllership and Principal Accounting Officer
Executive
Johanna Mercier
Chief Commercial Officer
Executive